Background: the worldwide number of dementia cases is increasing, and this is a trend that is expected to continue as a growing proportion of the population ages. However, conducting research with persons suffering from dementia can be fraught due to fears surrounding research risks in vulnerable populations. This can make seeking approval for studies difficult. As research directly involving persons with dementia is key for the development of evidence-based best practice, the development of a coherent ethical strategy to perform such research feasibly and effectively is of paramount importance. Objective: this paper aims to review and synthesise ethical challenges in performing research with persons who have dementia. Methods: in undertaking a systematic review of the current research literature, we will identify the central issues and arguments characterising research that concerns the ethical dimensions of research participation in the dementia population. Data were analysed using both inductive and deductive content analysis. Ethical considerations in research involving persons with dementia primarily concern the representation of the interests of the person with dementia and protection of their vulnerabilities and rights. Results: a total of 2,894 results were returned from initial searches, following deduplication. In total, 2,458 were excluded at title review, and following abstract review 158 papers remained; 29 papers were included for analysis after full paper review and data extraction. Papers ranged between 1995 and 2013. Conclusion: this review has highlighted a lack of consensus in current research and guidelines addressing these concerns; a clear stance on ethical governance of studies is important for future research and best evidence-based practice in dementia.
Background
The number of dementia cases is increasing continuously, and this is a trend that is expected to continue as a growing proportion of the population worldwide lives into old age [1] . Governments in industrialised countries have called for urgent actions as they acknowledge the growing human and economic costs of dementia, the second largest cause of disability for the over-70s, estimated costs of $645 billion per year globally [2] . The need for research into treatment for dementia as well as palliation and care of its symptoms is well recognised [3] . However, conducting research with people suffering from dementia brings about a series of ethical concerns surrounding research risks in vulnerable populations which make seeking approval for, and conducting studies difficult [4] . There is further call for protection measures concerning privacy and confidentiality to ensure that research is undertaken with full respect to the human rights of people during the research process. However, the research process can be impeded by a lack of coherent guidance from governing bodies and institutions.
As research directly involving persons with dementia is key for the development of evidence-based best practice [5] , the development of a coherent ethical strategy to perform such research feasibly and effectively is of paramount importance. Research amongst the dementia population is an area with many obstacles. People with cognitive impairments may be routinely excluded from studies due to concerns about safeguarding vulnerabilities [6] and lack of ability to provide informed consent [7] which in turn feed into the production of a lack of autonomy for persons with dementia. However, the ethical implications of the wholesale exclusion of a population who may benefit from research participation have been called into question [8] .
This paper aims to review and synthesise how ethical challenges are operationalised in research with people who have dementia. In undertaking a critical appraisal of the current research literature, we will identify the central issues and arguments characterising research that concerns the ethical dimensions of research participation for dementia. In describing and appraising the origin and characteristics of these studies, we aim to assess the suitability of the evidence to guide research governance in dementia research and proffer suggestions for the future ethical guidance of research amongst this population.
Methods
Following the method outlined in Duke [9] , this review aims to combine the scope and detail of the narrative review process with the rigour and methodology of systematic review. Data were analysed using both inductive and deductive content analysis, in order to effectively analyse quantitative and qualitative data in a systematic and comprehensive way. A team of researchers designed and implemented the search strategy with the aim of retrieving articles that addressed ethical considerations in a sufficiently detailed way to be included in the title, abstract, topic or key words. Hand searches were carried out in reference lists of retrieved articles, and archives of key journals were also searched to ensure that relevant articles were not missed in database searches. Journals were selected for handsearching if they contained a high frequency of relevant articles as identified through database search.
Search strategy
The search strategy detailed in Figure 1 was used to identify papers concerning participation of persons in dementia research with a clear and specific focus on the ethical aspects of the study process.
Searches were undertaken in the following electronic databases: Medline, PsycINFO, Cochrane Library, Web of Science, Sociological Abstracts, CINAHL.
Grey literature was also searched and key researchers contacted. Grey literature (in the form of policy documents and conference proceedings) was obtained through contacting key researchers, experts and policymakers through professional body and network membership. This was performed with the intention of citing the scientific literature within the wider societal context. A total of 2,894 results were returned from initial searches, following deduplication. This sample included randomised control trials, studies with nonrandomised sampling (including purposive sampling) and reviews of guidelines and past research. Designs included ranged from clinical trials to qualitative research, and overviews of multiple research studies in or between institutions.
During the screening process, E.W. and M.G. resolved doubt on in/exclusion by discussion. In total, 4,375 papers were identified in the initial search, and after deduplication 2,894 papers remained. Papers were first assessed at title review, and 2,458 were excluded leaving 436 papers to be reviewed at the abstract level. After abstract review, 158 papers remained-ranging from 1982 to 2014. Following full paper review and data extraction, 29 papers were included for analysis (Supplementary data are available in Age and Ageing online). Papers selected ranged between 1995 and 2013.
Non-research papers-such as editorials, discussion papers, non-intervention-based reviews and abstracts-were excluded. Papers included explicitly focused on the ethical considerations of person-centred research in the dementia population-papers were included if they focused on the experience of persons likely to develop dementia, people with dementia at all disease stages and sub-classifications and carers being involved in research and had a definite focus on ethical considerations. Papers were excluded if they were purely focused on assessing quality of care. Papers were also excluded at screening if research concerned only consideration of the proxy role without explicit reflection on the individual's experience. The proxy role was defined as the experiences and actions of an individual appointed to take decisions on behalf of a person with dementia. If papers considered only this individual's experiences, without reflection on the implications for the patient, they were excluded. The process of including and excluding studies is detailed in the PRISMA [10] flow diagram (Supplementary data are available in Age and Ageing online). Studies included were reported in English (Figures 2 and 3 ).
Data extraction
Articles were managed in EndNote X7. Quality score, study aims, study design, data source and main findings were included in this table.
Assessment of quality
Each study was assessed for methodological quality using the assessment scale developed by Hawker et al. [11] for systematically assessing studies of diverse methods. Nine
Operationalising ethical challenges in dementia research areas of each paper were assessed and graded between one and four, allowing for a maximum score of 36 per paperthe 'ethics' category of the original measuring tool was omitted as this was the primary focus of the review, thus no papers which did not explicitly consider ethical aspects were included. Quality scoring was used as a means of indicating relative quality of the studies, as no cut-off score for quality-related exclusion was used.
Results
Articles included for analysis covered a wide breadth of designs and topics. The evidence base spanned North America and Europe. Trials ranged in size from 10 participants to studies and meta-analyses involving hundreds of persons with dementia and proxy respondents. Studies included covered a wide range of study designs. Thirteen studies were structured as reviews or overviews [14, 16, 19, 20, 22, 26, 27, 30, 31, 33, 36] . Eleven explicitly addressed ethical guidelines for research involving persons with dementia [13, 17, 21, 26, 27, 30, 31, 34, 36, 38, 40] . The majority of studies, 18 of the 29, were based on qualitative research. Three studies addressed a service-focused approach to the topic [14, 29, 38] , and 10 focused on clinical research [12, 13, 22, 27, 31, 32, 33, 36, 37] . The articles represented a variety of themes (Supplementary data are available in Age and Ageing online) and healthcare settings, both inpatient and outpatient. This echoes the variety of settings that dementia care E. West et al.
is delivered in across healthcare systems [3] . One paper used setting as a point of comparison for the data [38] , looking at differences between the home, day clinic and nursing home setting. Twenty-two articles explored the topic of informed consent [12-19, 22-26, 28-30, 32, 36-39] . Eight investigated advance directives within the context of research involvement of people with dementia [16, 21, 24, 27, 30, 36, 39] , and 13 explored the role of proxy or surrogates within the research process [16-19, 21-23, 26, 29, 30, 36, 39] . The vast majority of included studies considered the risk of research explicitly, and this was a key topic in 20 of the included studies. E.W., M.G. and J.S. designed and implemented the search strategy, EW performed data extraction and quality analysis and E.W. and M.G. collaborated on analysis.
Ethical issues concerning research recruitment
Ethical issues surrounding recruitment of people with dementia for research studies formed a large part of the collected data. Two-thirds of the studies explored the concept of 
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informed consent [12-19, 22-26, 28-30, 32, 36-39] . This was explored from a number of different viewpoints; from information provided before seeking consent to the process of seeking consent in different study designs. In a review of different study enrolment processes, Kass [22] found significant variability in approaches-with more comprehensive conversations taking place in drug study recruitment than non-drug studies. Exploring the process of informed consent can also shed light on issues not directly related to the research process, such as treatment process-in studying levels of information concerning informed consent between three different disease groups-namely persons with Alzheimer's disease, surrogates of critically ill children and cancer patients-one study found that Alzheimer's groups were less likely to have no treatment discussed with them as a medical option [13] . A number of studies looked at the recruitment process both for persons with dementia and their proxies and carers. Approximately a third of studies explored people's views regarding the involvement of proxies for consent and decision-making in both treatment and research [16-19, 21-23, 26, 29, 30, 36, 39] . Cubit [15] reported high levels of consent being provided by the individual's next of kin rather than the person themselves. Studies which explored the process of proxy enrolment reported decision-making focused on the well-being of the person with dementia, as opposed to a substituted judgement [22, 23] . However, issues concerning gatekeeping by carers and professionals and how this may impact on the participation of those with differing stages of dementia were also reported at two stages of the study process -initial recruitment and consent, and the assessment of the burden of interviewing on the individual with dementia [18] .
Research risks versus 'Do no Harm'
Risk within the research continuum was a recurrent feature in many of the papers selected. Twenty-three papers directly E. West et al.
addressed the concept of risks presented in research [12-14, 16, 21-26, 28, 30, 32-35, 38, 39] , often weighing different types of research against preconceived risk in order to explore ethical issues surrounding consent and burden of research. Risk was presented from a number of perspectives, from societal to risk to bodily integrity. Social risk was framed in terms of potential stigma and alienation on a community and employment level, of particular concern amongst an already-vulnerable population [31, 34] , whilst bodily or personal risk involved physical or psychological harm to the individual with dementia.
Understanding risk
As well as presenting specific situations where risk had to be assessed as part of the research process, a number of studies used hypothetical circumstances for analysis [21, 23 24, 25] , particularly in assessing persons with dementia and their (potential) proxy's views on procedures and medical decisions. A number of studies found that a distinctly lower proportion of proxies were willing to consent to invasive and potentially painful hypothetical procedures than nonbodily invasive forms of research [21, 23, 30] . A high rate of support for non-invasive studies was found-including when there was no intention or potential for direct benefit to the person with dementia [12, 21, 23, 24] . Scenarios that presented a significant risk or burden to the individual also reported high acceptability rates [24] . Assent from persons with dementia was mentioned to be implicit rather than explicit information to seek when individuals had a surrogate decision-maker, and proxy decisions were made with the well-being of the individual in mind [12, 22, 25] . Clinical risk was often framed as a specific issue, and the administration of drugs and procedures was considered as a separate issue, due largely to the prospect of physiological harm caused by the study intervention. Ten papers were based on clinical research [12, 13, 22, 27, 31, 32, 33, 36, 37] -the administration of drugs or therapies, or clinical measurements of symptoms or capacity. This included methodologically focused work, such as an assessment of the use of 'bridging studies' for pharmacological developments in the dementia population [33] . As bridging studies are designed to assess the risks and mechanisms of pharmacological compounds in different populations, assessing risk for vulnerable populations is of particular importance. The use of pharmacological placebos was highlighted as problematic regarding risk to the person with dementia through treatment or administration burden, especially when used long term [32] .
Advance directives
Advance directives are a specific means of codifying future preferences for treatment and research involvement. Seven papers specifically addressed recruitment within the context of advance directives [16, 21, 24, 27, 30, 36, 39] . In studies that used proxies, high rates of correlation were found between study partners of persons deemed both capable and incapable of providing their own informed consent [39] . Enrolment procedures for trials were documented as a guide to shape consent discussion, and more comprehensive discussions were recorded in drug than in non-drug studies [22] , such as questionnaires, participant observation and interviews. Collective decision-making including the individual with dementia, surrogate and other members of the person's community was reported [13, 22, 98, 39] .
Guiding future research
Many papers focused on shaping or guiding future research within an ethical framework. Twelve papers were structured as reviews or overviews [14, 16, 19, 20, 22, 26, 27, 30, 31, 33, 36] . Three papers were health services research focused, exploring the structural aspects of research through analysis of ethical guidelines and research policies implemented institutionally [14, 29, 38] . Studies that assessed guidelines from a number of centres found large differences in how information was delivered, and the emphasis put on different parts of national or regional guidelines between centres [20, 26, 27] . Justification for particular approaches also differed radically between settings [26, 27] .
Other papers aimed to provide guidance for future research priorities [13, 17, 21, 26, 27, 30, 31, 34, 36, 38, 40] . This was found at every level of research-from macrofocus papers to suggestions for individual research practice. On a macro-level, key themes identified included cost effectiveness of research, therapeutic benefit, consent, confidentiality and the implication of gathered information [16, 31, 36] . A reflection on the ethics protocol of a multimethod qualitative study highlighted the importance of having a reflexive and dynamic ethics protocol to serve the complex needs presented during the study period [38] as the lack of reflexivity within the study protocol proved problematic. Knopman et al. [26] focused on the need to identify and test tools to assess capacity of persons with dementia in order to facilitate decisions concerning participating in research.
Recommendations included a codified ethical standpoint and process of self-reflection for individual researchers [19, 27, 28, 32, 38] . This was provided through recommendations for training in moral sensitivity, self-reflection and reflexivity [27] . Consideration of the balance between effective research and safeguarding was particularly encouraged [15, 19, 28, 29, 32] . Narrative analysis of ethics focused human dementia research, highlighting the definition of capacity, best interests, assent and dissent as key issues for further research, alongside further considerations of risk as a gap in existing guidelines [16] . Problems with guidelines that strongly limited which people could participate in terms of disease stage and assessment of capacity were also reported in two papers in the selection-the trials implicated eventually had to be abandoned due to inadequate recruitment [17, 38] .
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Discussion
This study was undertaken to explore the range of ethical issues and arguments represented in the research literature surrounding the involvement of persons affected by dementia in research. Through analysis of the studies found, the complexity and range of considerations for person-centred dementia research across all stages of the recruitment and study process has emerged. This complexity appears to be present across all levels of those involved in research-from individuals to institutions and advisory boards. The number of, sometimes conflicting, guidance structures accessed by research teams has also been shown-and the lack of a coherent and unified code of conduct was highlighted throughout the results. In assessing data based on experimental studies-either at the primary level or synthesis of experimental data-this review gives an oversight of issues directly experienced within the research process. Both qualitative and quantitative studies were well represented within the review, giving a broad indication of the issues at hand in each.
This review was limited by the fact that searches were limited to English language results and no electronic searches were performed in languages other than English. An international comparison of ethical issues would be beneficial to the research state of the art. However, the results presented represent a range of research issues that are likely to be applicable internationally.
Ethical considerations in research recruitment
The research process highlights a number of ethical concerns at different stages.
A key focus of many of the papers included for analysis concerned the recruitment and enrolment process for persons with dementia and their proxies and/or carers. Data were gathered that addressed ethical issues in the recruitment process throughout all stages of recruitment-from pre-provided information to the process of determining capacity to consent and potential problems with allowing proxy consent when the individual is not deemed capable or wants to interrupt the research or interview. A number of studies utilised hypothetical scenarios for decisionmaking. There is a current paucity of research on this methodological approach, and indeed this is a key area for future research in the field.
Consent
Informed consent as required in the Declaration of Helsinki on research ethics [40] remains one of the main concerns of the current debate. The assessment of capacity to consent is a fundamentally problematic issue in research involving persons with dementia as it calls on the capacity to understand and the capacity to discriminate information provided-capacities that are called into question by the nature of the disease. It is widely agreed that a diagnosis of dementia is not immediately a signifier of a lack of capacity to consent, and thus capacity must be judged on an individual basis [7] . A number of scales and measurements exist to assess capacity to consent, though a verified 'gold standard' in assessing capacity is not currently agreed-and the prospect of reaching a definitive indicator has been called into question [41] .
Capacity
When the capacity of an individual is determined to be too low or too inconsistent to provide informed consent to participate in a research study, proxy decision-makers can be utilised. This can also prove problematic, as there is no clear consensus on which types of research proxy respondents should be permitted to enrol an individual in-illustrated by previous decisions limiting risky or invasive research to persons who could provide their own consent. Kim et al. [42] found differing levels of capacity to consent according to the research scenario-high risk, invasive research and a drug RCT-alongside measurement of the capacity to appoint a proxy respondent. The capacity to appoint a proxy respondent was found to be preserved even when the capacity to consent to research was not. This, in conjunction with research that highlights the proxy decision-making process and its alignment with that of people with dementia, indicates that proxy representation for the incapacitated person in research is a feasible tool for research enrolment.
Capacity to consent is affected by a number of factors, and may fluctuate throughout time according to medication levels, hydration status and symptomatic factors such as constipation and pain. These elements may constitute a bias in the criteria for people with dementia to be able to consent or understand the information provided to them. A shift in the concept of consent from a one-off action to a continual process has been posited as a means to protect the person with dementia during the research process. A growing body of research literature [18, 29, 43, 44] recommends the practice of process consent consultation in research involving persons with dementia.
Vulnerability
The primary concern reflected in the wider literature surrounds vulnerability [47]-this is expressed in a number of ways in research, from obtaining consent to the risks of the research process. In the data gathered during this review, these concerns are echoed, and specific areas of concentration found. The review highlights that a particular area of concern when considering the ethical issues involved in the research process surrounds the lack of coherence in guidelines and decisions concerning vulnerability between studies or between institutions. Furthermore, social and environmental determinants of health have often been neglected, though they are of paramount importance in treatment and research amongst vulnerable groups to ensure equity of access to healthcare and treatment for all.
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Today, they are one of the top priorities of the WHO Strategic plan 2013-2019.
Guidelines
Practice guidelines for monitoring process consent in both verbal and non-verbal persons with dementia have been described in the research literature [45] . There was a lack of discussion in the included studies about issues surrounding confidentiality of data through wider ICT and health systems structures and about conditions of research when studies were interrupted through the ill health or unease of the person with dementia. The World Health Organization has produced a training manual on ethical issues in international research [46] where a specific case addresses the situation of an old person who becomes agitated and confused during the interview process. Though this training manual exposes international guidelines in its introduction, targeted recommendations have not been specifically formulated for old age or dementia research. Guidelines must continuously balance considerations of both constraint and consistency, and future developments should be made with this in mind.
What this paper adds to the evidence base
In order to guide future research governance and suggest future ethical considerations for guiding research, the results of this review must be contrasted with the current state of research surrounding the ethics of research in the population who have dementia.
An overarching theme throughout the data gathered was the lack of consensus in ethical guidelines for involving those with dementia in research, and the confusion that this could cause across or between institutions and national boundaries. This permeated all stages of the research process, from the individual to consortium level. Ngo and Holroyd-Leduc [48] highlight the current lack of uniformity in legislating for best practice in informed consent at a number of levels. Despite numerous laws and statutes set up to regulate the research process on an international level, implementation differs across countries due to differing interpretation of terms and interactions with national legislation and regulations. Many papers in our database aimed to address this lack of consensus, or identify the range of guidance currently available [49, 50] . A similar set of circumstances has been involved in best-practice treatment for dementia-finding agreement across guidelines for key recommendations, but no clear consensus [51] .
Implications for policy and practice
This study highlights a number of implications for future policy and practice, throughout the research process. Requiring informed consent from persons with dementia enroling in research trials brings into question the generalisability of studies that exclude the proportion of the dementia population only capable of providing consent via proxy. By definition, people deemed capable of providing their own informed consent are a high-functioning subgroup of the dementia population and thus are unlikely to be representative of the dementia population as a whole. Likewise, care should be taken to not alienate willing participants, especially in low-risk research studies. Non-therapeutic research with people with dementia has previously found that participants experience the research process as being beneficial to them, in that they are listened to and can contribute data that will help those with dementia in the future [52, 53] . A key focus for future research should be measuring the veracity and validity of research involving hypothetical scenarios, especially in groups where dementia has been diagnosed but decisional capacity is still high. Advance directives can allow people to specify their willingness to be involved in research before they lose capacity to consent, or can specify ahead of time a research proxy to act on their behalf. The use of advance directives to specify such preferences can allay uncertainties surrounding suitable choice of proxies and the coordination of proxy decisions with the wishes of those with dementia.
Conclusions
Ethical considerations of research involving persons with dementia have been shown to primarily concern the representation of the interests of the individual with dementia and protection of their vulnerabilities and rights. This review has highlighted that there is a lack of consensus in current research guidelines addressing these concerns. The importance of including persons with dementia in research is widely established; however, the practicalities of this can be difficult due to a lack of agreement on ethical standards concerning recruitment and the issue of risk in research. The failure to include this vulnerable group in studies could contribute to further harm by hampering evidence-based practice and biasing results and data interpretation, and thus a clear stance on ethical governance of studies involving persons with dementia is of primary importance for future research in this area. The World Report on Alzheimer [54] recommended that research funders and ethics committees should not fund or approve study designs that are not planned with a clear ethical framework in place at all stages-from diagnostic procedures to informed consent to misinterpretation of results through biased recruitment procedures.
Future research is likely to involve increasing amounts of personal data and the collection of biomaterial and behavioural data for predictive and therapeutic purposes. Thus, these concerns will become even more pressing. The Organisation for Economic Co-operation and Development (OECD) discusses issues concerning informed consent in its latest report, and underlines that a process of constant reconsenting would be costly and time-consuming. A series of potential alternatives such as a step-by-step consent model or more adaptive and dynamic types of consent forms that allow alterations to consent choices in real time have been proposed and approved by various research institutions.
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In March 2015, the WHO Ministerial Conference highlighted the need 'to establish norms/standardize clinical trial methodology and ethics of conducting research with new pharmacological agents, and non-pharmacologic interventions for diseases causing dementia' [54] . The quality of future research concerning interventions for persons affected by dementia and their proxies must implement adapted ethical standards requiring both basic and continuous education on ethical standards in research and care.
Key points
• Dementia is an increasingly important public health issue, but research can be hampered by concerns about the vulnerability of the population.
• This paper aims to review and synthesise ethical challenges in performing research with persons who have dementia.
• Results show that there is a lack of consensus in current research and guidelines.
• A coherent and clear stance on ethical governance in dementia research will help to advance best practice in research and evidence-based care.
